Drug Profile
Research programme: metabotropic glutamate receptor antagonists - Schering-Plough
Latest Information Update: 30 Nov 2009
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class Imidazoles; Indoles; Morpholines
- Mechanism of Action Metabotropic glutamate receptor type 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 23 Aug 2007 Preclinical trials in Pain in USA (PO)